Medtronic: A 25-Year Acquisition History of the Global MedTech Leader — Triumphs and Setbacks

Dec 27, 2024 22:14 CST Updated 22:14

Medtronic

Medical Device Manufacturer

In 1949, Medtronic was founded in Minnesota, USA.Founded in a small garage in Minneapolis, it has grown into the world's leading medical device company after 75 years of development.。

Medtronic's rise as the leading medical device company can be attributed not only to its culture of innovation (a relentless pursuit of innovation) and excellent management team, among other factors, but more importantly, to its successful history of mergers and acquisitions. Each acquisition either brought Medtronic into a new field or strengthened its position in an existing one (even making it the No. 1 in that field). The 2015 acquisition of Covidien allowed Medtronic to surpass Johnson & Johnson in one fell swoop, becomingMedtronic, the top player in the device industry, has consistently dominated the rankings ever since.

The following are Medtronic's twelve most important acquisitions in the past 25 years, which not only made Medtronic the top player but also solidified its leading position in the medical device field.However, these twelve acquisitions were not all successful; there were a few failed cases, such as the acquisitions of HeartWare and Physio-Control. Therefore, acquisitions are a technical task that requires detailed analysis of the target. If the analysis is not thorough, even the "top player" can suffer significant losses.

【01】Physio-Control

1998 | $538 million

Medtronic Acquires for $538 MillionPhysio-Control 。Physio-Control is a leading manufacturer of external defibrillator monitor products. Through the acquisition of Physio-Control ，Strengthens Medtronic's Position in the Defibrillator Monitor MarketHowever, the good times did not last long. Eight years later, in 2006, Medtronic split.Physio-Control, which eventually became part of Stryker.

【02】Arterial Vascular Engineering

1998 | $3.7 Billion

Medtronic Acquires Arterial Vascular Engineering for $3.7 Billion. Arterial Vascular Engineering is a leading manufacturer of stent products. The acquisition of Arterial Vascular Engineering made Medtronic the largest stent manufacturer in the world at that time.

【03】Sofamor Danek Group

1999 | $3.6 Billion

Medtronic Acquires Sofamor Danek Group for $3.6 Billion. Sofamor Danek Group is a leading manufacturer of spinal products. The acquisition of Sofamor Danek Group expands Medtronic's market share in the spinal sector, establishing the company as a leader in the field of spinal disease treatment andStrengthened its position in the broader musculoskeletal field. In 2005, Medtronic also paid Dr. Gary K. Michelson due to intellectual property issues with the Sofamor Danek Group.$1.35 Billion Settlement: Medtronic AcquisitionThe cost of the Sofamor Danek Group is still very expensive.

【04】MiniMed

2001 | $3.7 billion

Medtronic Acquires MiniMed for $3.7 BillionMiniMedIs a leading insulin pump manufacturer. Medtronic acquisitionMiniMed, which has brought Medtronic into the diabetes treatment field and made Medtronic the leading company in this field.。

【05】kyphon

2007 | $3.9 Billion

Medtronic Acquires Kyphon for $3.9 BillionkKyphon is a leading manufacturer of spinal products. This is a significant acquisition by Medtronic in the spinal field. The acquisition of Kyphon has solidified Medtronic's position in minimally invasive spinal surgery solutions, complemented its existing spinal product portfolio, and driven growth in high-value, rapidly developing market segments.

【06】CoreValve

2007 | $1 billion

Medtronic Acquires CoreValve for $1 Billion. CoreValve is a leading manufacturer of TAVR products. Through the acquisitionCoreValve, making Medtronic a leader in the interventional valve field. Today, Medtronic relies onCoreValvThe upgraded TAVR product --- Evolut, is expected to become the world's leading TAVR.

【07] Kanghui

2012 | $816 million

Medtronic Acquires Kanghui for $816 Million. Kanghui is a leading Chinese domestic orthopedic product manufacturer. Through the acquisition of Kanghui, Medtronic has expanded its influence in China, the world's second-largest medical device market, particularly in the orthopedic market.

【08] Covidien

2015Year | $42.9 Billion

Medtronic429Acquired Covidien for billions of dollars, Covidien is a top ten global medical device company. This is an unprecedented acquisition in Medtronic's history (the history of the global medical device industry), where the world's fourth largest company merges with the tenth largest, ultimately overturning Johnson & Johnson's dominance in the medical device industry, becoming...Instrument Big Brother.

【09】HeartWare

2016Year | $1.1 Billion

Medtronic at 11Acquired Heart for $ billionWare. HeartWare is a leading manufacturer of left ventricular assist devices. This acquisition by Medtronic turned out to be one of the biggest blunders in Medtronic's acquisition history, not only wasting $1.1 billion but also facing enormous compensation.HEartWare's products have exited the market, and Medtronic has also exited.Left Ventricular Assist Device Market.

【10】Mazor Robotics

2018Year | $1.64 billion

Medtronic Acquires Mazor Robotics for $1.64 Billion. Mazor Robotics is a great acquisition by Medtronic in the spine field, combining surgical robotics with existing surgical technologies to strengthen Medtronic's absolute leadership in the spine sector.

【11】Affera

2022 Years | $9.25 Billion

Medtronic Acquires Affera for $925 Million. Affera represents a significant acquisition for Medtronic in the electrophysiology field, as it not only grants Medtronic advanced radiofrequency ablation and PFA technologies but also provides the highly coveted 3D mapping technology. This enables Medtronic to challenge Johnson & Johnson and potentially become the leading player in electrophysiology in the future.

【12】Intersect ENT

2022 Years |11Billion US dollars

Medtronic Acquires Intersect ENT for $1.1 Billion. Intersect ENT is a leading supplier of chronic rhinosinusitis treatment technologies. The acquisition expands Medtronic's ENT surgery portfolio and enhances its chronic rhinosinusitis treatment offerings, enabling Medtronic to provide comprehensive solutions for chronic rhinosinusitis patients, including radiofrequency ablation, sinus irrigation systems, sleep-disordered breathing products, and targeted drug delivery. This further solidifies Medtronic’s leadership position in the chronic rhinosinusitis field.